Headline
The latest stories from AHA Today.
The House passed the Dr. Lorna Breen Health Care Provider Protection Act (H.R. 1667), AHA-supported legislation that would authorize grants for programs that offer behavioral health services for front-line health care workers.
The Food and Drug Administration authorized using the combination monoclonal antibody therapy Evusheld to help prevent COVID-19 in certain adults and children with compromised immune systems or a history of severe adverse reaction to a COVID-19 vaccine or its components.
The Food and Drug Administration announced the widely anticipated expansion of Pfizer’s COVID-19 vaccine emergency use authorization to allow booster doses for 16- and 17-year-olds.
The AHA released a new issue of the COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
A bipartisan group of senators urged Majority Leader Chuck Schumer and Minority Leader Mitch McConnell to extend through the end of the COVID-19 public health emergency the moratorium preventing a 2% cut to Medicare payments under sequestration.
New Hampshire hospitals and their health care heroes recently received the Distinguished Industry of the Year Award from the Daniel Webster Council of the Boy Scouts of America for their service, sacrifice and courage throughout the COVID-19 pandemic.
The Health Resources and Services Administration awarded states and territories an additional $81 million in emergency funding from the American Rescue Plan Act for the Maternal, Infant, and Early Childhood Home Visiting Program, which provides voluntary home visits to improve maternal and child…
Primary and behavioral health organizations, state and local governments and others can apply through Feb. 7 for a portion of $30 million from the American Rescue Plan Act to expand community-based drug overdose prevention programs, the Substance Abuse and Mental Health Services Administration…
Pfizer released preliminary laboratory findings on its COVID-19 vaccine’s effectiveness against the SARS-CoV-2 Omicron variant, offering an early look at the two, distinct dosing regiments currently authorized in the U.S.
The Centers for Medicare & Medicaid Services will continue to exercise discretion in enforcing compliance with the payer-to-payer data exchange provisions of its 2020 final rule on interoperability and patient access until it finalizes future rulemaking to address implementation challenges, the…